captopril has been researched along with acebutolol in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (17.39) | 18.7374 |
| 1990's | 6 (26.09) | 18.2507 |
| 2000's | 7 (30.43) | 29.6817 |
| 2010's | 6 (26.09) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Asakawa, T; Fujinami, T; Hayano, J; Kako, T; Kato, T; Koketsu, M; Yoneda, S | 1 |
| Abrignani, MG; Corda, M; Cosentino, F; Liquori, M; Novo, S; Pinto, A; Strano, A | 1 |
| Esnault, VL; Ginet, JD; Guenel, J; Le Carrer, D; Potiron-Josse, M; Testa, A | 1 |
| Dubos, JP; Gremillet, C; Kacet, N; Lequien, P; Morisot, C; Remy-Jardin, M | 1 |
| Basciu, M; Cherchi, A; Pili, G; Sau, F; Seguro, C; Siddi, PP; Tamponi, R | 1 |
| Chatellier, G; Comoy, E; Corvol, P; Ménard, J; Plouin, PF; Rougeot, MA | 1 |
| Azancot, A; Gainet, B; Loirat, C; Macher, MA; Mathieu, H; Mouchet, B; Pillion, G | 1 |
| Wiechmann, HW | 1 |
| Airoldi, G; de Divitiis, O; Di Somma, S; Fazio, S; Galderisi, M; Liguori, V; Petitto, M | 1 |
| Azuma, T; Fujimoto, T; Funauchi, M; Matsubara, T; Nagai, Y; Saito, T; Sakoda, S; Tone, K | 1 |
1 review(s) available for captopril and acebutolol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
6 trial(s) available for captopril and acebutolol
| Article | Year |
|---|---|
Single administration of captopril and combined use with beta-blocker and/or thiazide diuretic in the treatment of essential hypertension.
Topics: Acebutolol; Adrenergic beta-Antagonists; Aldosterone; Benzothiadiazines; Blood Pressure; Captopril; Diuretics; Drug Therapy, Combination; Furosemide; Heart Rate; Humans; Hypertension; Middle Aged; Potassium; Renin; Sodium; Sodium Chloride Symporter Inhibitors | 1991 |
Regression of structural vascular changes after chronic treatment in hypertensives.
Topics: Acebutolol; Adult; Aged; Blood Pressure; Captopril; Female; Hemodynamics; Humans; Hypertension; Labetalol; Leg; Male; Metoprolol; Middle Aged; Regional Blood Flow; Vascular Resistance | 1991 |
Captopril but not acebutolol, prazosin or indomethacin decreases postexercise proteinuria.
Topics: Acebutolol; Adult; Albuminuria; Captopril; Exercise; Female; Hemodynamics; Humans; Indomethacin; Prazosin; Proteinuria; Renin-Angiotensin System | 1991 |
[Electrocardiographic and echocardiographic changes during antihypertensive therapy].
Topics: Acebutolol; Adolescent; Adult; Aged; Antihypertensive Agents; Captopril; Cardiomegaly; Chlorthalidone; Echocardiography; Electrocardiography; Female; Humans; Hypertension; Indenes; Male; Middle Aged; Nifedipine; Oxprenolol; Pindolol; Propanolamines; Timolol | 1990 |
[Hemodynamic effects of different antihypertensive combinations].
Topics: Acebutolol; Antihypertensive Agents; Captopril; Chronic Disease; Diuretics; Drug Evaluation; Drug Therapy, Combination; Female; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Piperazines; Random Allocation; Sulfonamides; Time Factors | 1988 |
Effects of antihypertensive agents on circadian blood pressure in hypertensive patients with previous brain infarction.
Topics: Acebutolol; Aged; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Calcium Channel Blockers; Captopril; Cerebral Infarction; Circadian Rhythm; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Heart Rate; Humans; Hypertension; Male; Middle Aged; Nifedipine; Secondary Prevention; Treatment Outcome | 1997 |
16 other study(ies) available for captopril and acebutolol
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Cheminformatic models to predict binding affinities to human serum albumin.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids | 2001 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics | 2011 |
Neonatal hypertension and thrombosis of the ductus arteriosus.
Topics: Acebutolol; Captopril; Child, Preschool; Ductus Arteriosus; Female; Follow-Up Studies; Humans; Hydralazine; Infant, Newborn; Persistent Fetal Circulation Syndrome; Radiography; Renal Artery; Renal Artery Obstruction; Thrombosis | 1991 |
Plasma renin activity in phaeochromocytoma: effects of beta-blockade and converting enzyme inhibition.
Topics: Acebutolol; Adrenal Gland Neoplasms; Adrenergic beta-Antagonists; Adult; Angiotensin-Converting Enzyme Inhibitors; Captopril; Female; Humans; Hypertension; Male; Norepinephrine; Pheochromocytoma; Renin | 1988 |
Sequential echocardiographic study prior and during antihypertensive therapy in children with severe hypertension.
Topics: Acebutolol; Adolescent; Antihypertensive Agents; Captopril; Cardiomegaly; Child; Child, Preschool; Echocardiography; Follow-Up Studies; Humans; Hypertension; Infant | 1986 |
[Therapeutic approach to arterial hypertension: comparison and combination of acebutolol with nifedipine and captopril].
Topics: Acebutolol; Captopril; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Nifedipine; Random Allocation | 1985 |